Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1994-11-17
pubmed:databankReference
pubmed:abstractText
The FIS variant is a weakly leukemogenic, relatively strong immunosuppressive murine retrovirus which was isolated from the T helper cells of adult NMRI mice infected with Friend murine leukemia virus (F-MuLV) complex (FV). Unlike FV, it does not induce acute erythroleukemia but retains the immunosuppressive property of FV and induces suppression of the primary antibody response rapidly and persistently in adult mice. A previous study showed that the FIS variant contains two viral components, a replication-competent virus and a defective virus. In this study, we have biologically purified the FIS variant by end point dilution and we show that the replication-competent virus FIS-2 alone can induce immunosuppression as the parental FIS variant. Most newborn mice infected with FIS-2 developed erythroleukemia, but with an increased latency period compared with that of F-MuLV clone 57. In contrast, FIS-2 induced suppression of the primary antibody response and disease more rapidly than F-MuLV clone 57 in immunocompetent, adult mice. FIS-2 was further molecularly cloned and characterized. Restriction mapping and nucleotide sequence analysis of FIS-2 showed a high degree of homology between FIS-2 and F-MuLV clone 57, suggesting that FIS-2 is a variant of F-MuLV. The striking difference is the deletion of one of the tandem repeats in the FIS-2 long terminal repeat and the single point mutation in the binding sites for core-binding protein and FVa compared with the long terminal repeat of F-MuLV clone 57. Two single point mutations led to the appearance of two extra potential N glycosylation sites in the FIS-2 gag-encoded glycoprotein. Together, the results suggest that FIS-2 represents an interesting murine model to study retrovirus-induced immunosuppression on the basis of its unique combined property of low leukemogenicity and relatively strong and persistent immunosuppressive activity in adult mice.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-1527847, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-1620621, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-1717587, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-1762923, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-1850020, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-1850169, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-1921761, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2052545, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2154701, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2195116, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2425028, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2524528, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2536834, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2538626, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2648393, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2778872, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2783259, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2926863, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-2996136, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-3013424, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-3023887, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-3033265, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-317564, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-3456010, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-3468264, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-3499609, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-363600, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-4207729, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-4705382, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-4921785, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6092722, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6165830, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6246170, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6298471, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6308605, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6308622, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6311904, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6323995, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6459295, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-6996726, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-7288927, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-7678475, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-7690416, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-8235449, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-8347077, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-8370071, http://linkedlifedata.com/resource/pubmed/commentcorrection/7933079-8513493
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6976-84
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2.
pubmed:affiliation
Unigen Center for Molecular Biology, University of Trondheim, Norway.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't